ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2438

Increased Risk of Postpartum Depression in SLE Pregnancies

Evelyne Vinet1, Susan Scott2, Debbie Ehrmann Feldman3, Christian A. Pineau4 and Sasha Bernatsky2, 1Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, 4McGill University Health Centre, Montreal, QC, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: depression, pregnancy and systemic lupus erythematosus (SLE), Reproductive Health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Reproductive Issues in Rheumatic Disorders - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic diseases have been shown to be a strong risk factor for postpartum depression. Although there is a 2-fold increased risk of major depression in SLE, the risk of postpartum depression in mothers with SLE is unknown. Within a large population-based cohort, we evaluated the risk of postpartum depression in women with SLE compared to unaffected women and explored potential mediators of postpartum depression in SLE pregnancies.

Methods: The “Offspring of SLE mothers Registry (OSLER)” includes all women who had ≥1 hospitalization for delivery after SLE diagnosis, identified through Quebec’s universal healthcare databases (1989-2009). OSLER also includes a randomly selected control group of women, matched at least 4:1 for age and year of delivery, without an SLE diagnosis prior up to the time of delivery. We ascertained postpartum depression based on ≥1 hospitalization or physician visit with relevant diagnostic codes, within the first 12 months after delivery. We performed multivariate analyses to adjust for maternal education, race/ethnicity, and pre-existing mood disorders in the 2 years prior to delivery. In secondary analyses, we further adjusted for pregnancy complications, including preterm birth, gestational diabetes, and stillbirth, to explore potential mediators of postpartum depression in SLE pregnancies.

Results: 509 women with SLE had 729 births, while 5824 matched controls had 8541 births. We identified postpartum depression in 11.0% (95% CI 8.8, 13.5) of SLE pregnancies versus 8.3% (95% CI 7.7, 8.9) of unexposed pregnancies. More SLE pregnancies were preceded by a mood disorder in the 2 years prior to delivery as opposed to unexposed pregnancies [15.4% (95% CI 12.9, 18.2) vs 11.0% (95% CI 10.2, 11.5)]. In primary multivariate analysis, accounting notably for pre-existing mood disorders, SLE pregnancies were at increased risk of postpartum depression versus unexposed pregnancies [OR 1.32 (95% CI 1.01, 1.73)]. The effect estimate for SLE was attenuated when we further adjusted for pregnancy complications [OR 1.20 (95% CI 0.92, 1.58)]. Preterm birth [OR 1.55 (95% CI 1.20, 2.00)] and stillbirth [OR 6.49 (95% CI 3.32, 12.67)] were independent predictors of postpartum depression. Pre-existing mood disorders in the 2 years prior to delivery also was an independent predictor of postpartum depression in both primary and secondary multivariate analyses [OR for primary analysis 4.44 (95% CI 3.73, 5.29)].

Conclusion: Compared to women from the general population, women with SLE have an increased risk of postpartum depression. Mediators of postpartum depression in SLE potentially include pregnancy complications, such as preterm birth and stillbirth. Further research is needed to evaluate the role of disease activity and/or flare during pregnancy, as well as medication exposures on the risk of postpartum depression in SLE.


Disclosure: E. Vinet, None; S. Scott, None; D. Ehrmann Feldman, None; C. A. Pineau, None; S. Bernatsky, None.

To cite this abstract in AMA style:

Vinet E, Scott S, Ehrmann Feldman D, Pineau CA, Bernatsky S. Increased Risk of Postpartum Depression in SLE Pregnancies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/increased-risk-of-postpartum-depression-in-sle-pregnancies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-postpartum-depression-in-sle-pregnancies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology